Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON (JNJ)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 06/22 10:02:31 pm
122.84 USD   +1.14%
11:08pJOHNSON & JOHNS : current report
PU
09:45pJOHNSON & JOHNS : Remakes Top Leadership -- Update
DJ
07:44pJOHNSON & JOHNS : Worldwide Chairman Peterson to Retire
DJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Most relevant news about JOHNSON & JOHNSON
11:08pJOHNSON & JOHNSON : current report
PU
09:45pJOHNSON & JOHNSON : Remakes Top Leadership -- Update
DJ
07:44pJOHNSON & JOHNSON : Worldwide Chairman Peterson to Retire
DJ
07:03pJOHNSON & JOHNSON : Announces Retirement of Group Worldwide Chairman, Sandra E. ..
PU
06:32pJOHNSON & JOHNSON : Appoints Senior Leaders to Executive Committee
PR
01:54pJOHNSON & JOHNSON : Janssen Phase 3 Study Programme of Esketamine Nasal Spray in..
AQ
06/20EXISTBI PROVIDE TABLEAU TRAINING TO : Exist Management LLC (ExistBI) See An Inc..
AQ
06/20JOHNSON & JOHNSON : Care centre gets gift of baby goods
AQ
06/20JOHNSON & JOHNSON : Pa. court backs $12.8M verdict against Johnson & Johnson sub..
AQ
06/19JOHNSON & JOHNSON : to Host Investor Conference Call on Second-Quarter Results
PR
06/19HILLENBRAND : Dudley in charge of Hillenbrand investor relations
AQ
06/18MARKETS RIGHT NOW : Stocks look to recover from early skid
AQ
06/18JOHNSON & JOHNSON : FDA Approves the Next Generation of Customized LASIK Treatme..
PU
06/18JOHNSON & JOHNSON : Janssen Pharmaceutical - XARELTO Associated with Significant..
AQ
06/15KYROS LAW IS INVESTIGATING CLAIMS ON : 1,100 Invokana Lawsuits Alleging Diabetic..
PR
More most relevant news
All news about JOHNSON & JOHNSON
11:08pJOHNSON & JOHNSON : current report
PU
11:04pJOHNSON & JOHNSON : Change in Directors or Principal Officers, Regulation FD Dis..
AQ
09:45pJOHNSON & JOHNSON : Remakes Top Leadership -- Update
DJ
07:44pJOHNSON & JOHNSON : Worldwide Chairman Peterson to Retire
DJ
07:03pJOHNSON & JOHNSON : Announces Retirement of Group Worldwide Chairman, Sandra E. ..
PU
06:32pJOHNSON & JOHNSON : Appoints Senior Leaders to Executive Committee
PR
01:54pJOHNSON & JOHNSON : Janssen Phase 3 Study Programme of Esketamine Nasal Spray in..
AQ
01:13pJOHNSON & JOHNSON : Governor Cuomo Announces Grand Opening of New Life Sciences ..
AQ
06/21JOHNSON & JOHNSON : Innovation Announces Launch of Shanghai Lung Cancer Innovati..
AQ
06/21JOHNSON & JOHNSON : Zurak Foundation Tackle Prostate Cancer
AQ
More news
Sector news : Pharmaceuticals - NEC
11:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
07:38aRoche to Appoint James Sabry as Head of Partnering
DJ
06/21LONDON MARKETS: FTSE 100 Drops As Oil Shares Extend Losses; Pound Rallies On ..
DJ
06/21Canada sets October start for legal recreational marijuana sales
RE
06/20GILEAD SCIENCES : GSK takes billion-dollar drug fight with Gilead to top AIDS me..
RE
06/20Roche to Buy Rest of Cancer Firm -- WSJ
DJ
More sector news : Pharmaceuticals - NEC
Official Publications
04/26Dividends 
04/171st quarter results 
03/31SEC Filing 10Q-1 
03/31SEC Filing 8K 
02/20Report 
02/15Report 
More official Publications
News from SeekingAlpha
12:42pJohnson & Jobnson chairman to retire 
10:13aHP INC. : Buy For Total Return And Gain From Share Buybacks 
12:41aThe No. 1 Stock In The World (Redux) - Part 3 
06/21Establishment Labs files for initial public offering 
06/21Forty Seven Readies $100 Million U.S. IPO 
06/21JOHNSON & JOHNSON : Strong Company, But Won't Fit In Most Portfolios 
Qtime:0
Financials ($)
Sales 2018 81 525 M
EBIT 2018 24 885 M
Net income 2018 16 158 M
Debt 2018 10 673 M
Yield 2018 2,96%
P/E ratio 2018 17,59
P/E ratio 2019 16,24
EV / Sales 2018 4,15x
EV / Sales 2019 3,85x
Capitalization 327 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 144 $
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Dominic J. Caruso Chief Financial Officer & Vice President
Paulus Stoffels Chief Scientific Officer & Executive VP
Charles O. Prince Independent Director
William David Perez Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON-12.27%327 330
PFIZER0.00%213 275
NOVARTIS-10.87%189 575
ROCHE HOLDING LTD.-12.58%188 417
MERCK AND COMPANY8.90%164 862
AMGEN7.07%123 415